Stay updated on Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial page.

Latest updates to the Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe Publications note was updated to indicate PubMed automatic population and possible non-study relevance. The revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding notice warning of potential delays and operating-status updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedPOLEM (NCT03827044) recruitment was halted and the study terminated after enrolling 30 participants; the page now reflects the updated status and enrollment details.SummaryDifference0.5%

- Check71 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference3%

- Check79 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision updated to v3.0.2 and the Back to Top element was removed.SummaryDifference0.2%

Stay in the know with updates to Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial page.